In addition, IHC analysis confirmed that DCLK1 inhibitor decreased the protein expression of DCLK1 and CCAR1 in subcutaneous tumour in both of DCLK1‐overexpressing and the control groups (Figure 8G). This evidence concerns the gene DCLK1 and neoplasm.